» Articles » PMID: 29228434

Functional Roles of Exosomes in Cardiovascular Disorders: a Systematic Review

Overview
Date 2017 Dec 12
PMID 29228434
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiovascular diseases are major causes of people death associated with high mortality and disability. Exosomes are nanosized extracellular vesicles containing protein, lipid, transcription factors, mRNAs, non-coding RNA (ncRNA) and nucleic acid contents, which are critical players of intercellular communication via long-range signals or cell-to-cell contact. The emergence of exosomes provides favorable strategies for the diagnosis and treatment of cardiovascular diseases. Exosomes-based molecular mechanisms are important for developing novel therapeutic approaches for cardiovascular events. In this review, we will (1) provide insights into the detrimental and beneficial effects of exosomes on cardiovascular physiology, (2) summarize the underlying biological mechanisms of the exosome in cardiovascular events, (3) investigate the therapeutic value of exosomes for cardiovascular disorders.

Citing Articles

Mesenchymal stem cells derived exosomes: a new era in cardiac regeneration.

Rayat Pisheh H, Sani M Stem Cell Res Ther. 2025; 16(1):16.

PMID: 39849585 PMC: 11756228. DOI: 10.1186/s13287-024-04123-2.


Benefits of Curcumin in the Vasculature: A Therapeutic Candidate for Vascular Remodeling in Arterial Hypertension and Pulmonary Arterial Hypertension?.

Li K, Wang Z, Ongachwa Machuki J, Li M, Wu Y, Niu M Front Physiol. 2022; 13:848867.

PMID: 35530510 PMC: 9075737. DOI: 10.3389/fphys.2022.848867.


Potential clinical applications of exosomes in the diagnosis, treatment, and prognosis of cardiovascular diseases: a narrative review.

Chen X, Luo Q Ann Transl Med. 2022; 10(6):372.

PMID: 35433929 PMC: 9011294. DOI: 10.21037/atm-22-619.


Exosomes in Cardiovascular Diseases: Pathological Potential of Nano-Messenger.

Jadli A, Parasor A, Gomes K, Shandilya R, Patel V Front Cardiovasc Med. 2021; 8:767488.

PMID: 34869682 PMC: 8632805. DOI: 10.3389/fcvm.2021.767488.


Semaphorin 7A knockdown improves injury and prevents endothelial-to-mesenchymal transition in ox-LDL-induced HUVECs by regulating β1 integrin expression.

Song X, Meng J, Yan G, Wang H, Li H, Lou D Exp Ther Med. 2021; 22(6):1441.

PMID: 34721683 PMC: 8549106. DOI: 10.3892/etm.2021.10876.